Haemonetics HAE Income Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| $346.35M+2.2% | $338.97M+3.6% | $327.32M+1.8% | $321.39M-2.8% | $330.6M-5.1% | ||
| $148.14M+8.5% | $136.58M+3.0% | $132.57M+2.6% | $129.15M-6.1% | $137.55M-11.3% | ||
| $198.21M-2.1% | $202.39M+3.9% | $194.74M+1.3% | $192.24M-0.4% | $193.05M-0.3% | ||
| 57.2%-2.5pp | 59.7%+0.2pp | 59.5%-0.3pp | 59.8%+1.4pp | 58.4%+2.9pp | ||
| $14.45M+1.8% | $14.19M-4.6% | $14.87M-8.5% | $16.26M-11.2% | $18.31M+15.6% | ||
| $120.93M+10.8% | $109.15M+7.4% | $101.62M-8.2% | $110.72M-3.8% | $115.14M+8.2% | ||
| $27.32M-0.2% | $27.39M-3.1% | $28.26M-1.7% | $28.76M+1.9% | $28.21M-2.8% | ||
| $221.24M+63.9% | $134.99M-0.9% | $136.25M-1.5% | $138.37M+13.7% | $121.72M-9.5% | ||
| —— | $67.4M+15.2% | $58.49M+8.6% | $53.87M-24.5% | $71.34M+20.8% | ||
| -$5.37M+27.6% | -$7.42M-3.0% | -$7.21M+17.2% | -$8.7M-1,355% | -$598K+93.4% | ||
| —— | $59.98M+16.9% | $51.29M+13.5% | $45.17M-36.1% | $70.74M+41.7% | ||
| —— | $15.24M+20.9% | $12.6M+13.1% | $11.14M-12.7% | $12.76M+2.7% | ||
| —— | $44.74M+15.7% | $38.68M+13.7% | $34.03M-41.3% | $57.98M+54.6% | ||
| —— | $0.95+17.3% | $0.81+15.7% | $0.70-40.2% | $1.17+58.1% | ||
| —— | $0.96+18.5% | $0.81+14.1% | $0.71-39.3% | $1.17+56.0% | ||
| 47.4M+0.8% | 47M-1.4% | 47.7M-1.4% | 48.4M-4.7% | 50.7M+0.2% | ||
| 47.2M+0.8% | 46.8M-1.7% | 47.6M-1.1% | 48.1M-4.4% | 50.3M+0.1% | ||
| $10.49M-4.0% | $10.93M-2.2% | $11.18M-1.8% | $11.39M+0.8% | $11.3M-7.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | -$2.06M-184% | -$725K+77.6% | -$3.23M— | —— | ||
| $21.64M0.0% | $21.64M0.0% | $21.64M0.0% | $21.64M+3,520% | $597.75K0.0% | ||
| —— | -$6.7M— | —— | -$47.9M— | —— | ||
| $22.24M+301% | -$11.06M-252% | $7.26M+304% | -$3.56M+65.6% | -$10.34M-684% | ||
| -$8.46M+38.9% | -$13.84M+36.4% | -$21.76M-560% | -$3.3M-1,005% | $364K-97.9% | ||
| $6.73M+46.0% | $4.61M-21.9% | $5.9M-66.8% | $17.79M— | —— | ||
| -$101.5M— | $0+100% | -$76.55M-3,035% | -$2.44M— | —— | ||
| -$86.61M-194% | -$29.47M+3.3% | -$30.47M+7.7% | -$33M— | —— | ||
| $70.94M-24.2% | $93.56M-16.0% | $111.32M+540% | $17.4M-85.1% | $116.56M+166% | ||
| -$5.37M+27.6% | -$7.42M-3.0% | -$7.21M+17.2% | -$8.7M-1,355% | -$598K+93.4% | ||
| $5.98M+188% | $2.07M+140% | $865K-52.3% | $1.81M-2.7% | $1.86M-48.1% | ||
| $100M— | —— | —— | —— | $150M— | ||
| $0— | $0— | $0— | $0— | —— | ||
| $17.66M+178% | $6.35M+26.6% | $5.02M+33.6% | $3.75M-76.0% | $15.64M+83.0% | ||
| -$13K+7.1% | -$14K+64.1% | -$39K-8.3% | -$36K-33.3% | -$27K+81.9% | ||
| $526K+21.8% | $432K+260% | $120K-59.6% | $297K-87.9% | $2.45M+876% | ||
| —— | $1.15M+1,721% | $63K-86.4% | $462K— | —— | ||
| —— | $1.56M+0.1% | $1.56M-0.1% | $1.56M0.0% | $1.56M+0.1% | ||
| —— | $338.97M+3.6% | $327.32M+1.8% | $321.39M— | —— | ||
| $9.13M+17.0% | $7.8M+2.8% | $7.59M-18.5% | $9.31M+34.2% | $6.94M-15.5% | ||
| —— | $67.4M+15.2% | $58.49M+8.6% | $53.87M-24.5% | $71.34M+20.8% | ||
| —— | $94.78M+9.3% | $86.75M+5.0% | $82.63M-17.0% | $99.54M+13.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Haemonetics's profit margins?
- Gross margin is 59.0% and operating margin is 19.0%, with a 13.3% net margin.
- Where does Haemonetics's income statement data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.